EyePoint Pharmaceuticals
EYPT
#5857
Rank
โ‚ฌ0.92 B
Marketcap
11,15ย โ‚ฌ
Share price
6.81%
Change (1 day)
51.83%
Change (1 year)

Market capitalization of EyePoint Pharmaceuticals (EYPT)

Market cap: โ‚ฌ0.92 Billion

As of February 2026 EyePoint Pharmaceuticals has a market cap of โ‚ฌ0.92 Billion. This makes EyePoint Pharmaceuticals the world's 5857th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of EyePoint Pharmaceuticals from 2005 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.92 B-28.36%
2025โ‚ฌ1.28 B172.95%
2024โ‚ฌ0.47 B-53.75%
2023โ‚ฌ1.02 B818.09%
2022โ‚ฌ0.11 B-69.65%
2021โ‚ฌ0.36 B352.66%
2020โ‚ฌ80.94 M-46.54%
2019โ‚ฌ0.15 B-3.92%
2018โ‚ฌ0.15 B286.79%
2017โ‚ฌ40.73 M-26.68%
2016โ‚ฌ55.56 M-57.46%
2015โ‚ฌ0.13 B31.4%
2014โ‚ฌ99.39 M26.66%
2013โ‚ฌ78.47 M268.24%
2012โ‚ฌ21.31 M19.85%
2011โ‚ฌ17.78 M-75.02%
2010โ‚ฌ71.19 M54.23%
2009โ‚ฌ46.15 M275.91%
2008โ‚ฌ12.27 M3006.76%
2007โ‚ฌ0.39 M-33.09%
2006โ‚ฌ0.59 M-99.67%
2005โ‚ฌ0.17 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of EyePoint Pharmaceuticals was reported to be:

โ‚ฌ0.86 Billion
by Nasdaq info icon info icon
โ‚ฌ0.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
โ‚ฌ15.45 M-98.33% Bahamas
NRC Health
NRC
โ‚ฌ0.30 B-67.31%๐Ÿ‡บ๐Ÿ‡ธ USA